Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Front Endocrinol (Lausanne) ; 13: 999331, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36093070

RESUMEN

Background and Aim: The incidence of differentiated thyroid cancer (DTC) has risen dramatically worldwide. Despite an excellent prognosis, the growing DTC survivors' community often features poor health-related quality of life (HRQoL), which challenges long-term DTC care, particularly in developing Southern Mediterranean and African countries. We aimed to assess the HRQoL and to investigate its determinants in disease-free Tunisian DTC survivors. Methods: We conducted a three-month cross-sectional study that included 266 patients diagnosed with DTC. We assessed the HRQoL in eligible participants using the short form-36 health survey, in comparison with 76 healthy controls. Results: The 86 eligible DTC survivors were predominantly female (89.5%) with an average age of 44.3 ± 12.5 years. Physical-functioning (PF), role-physical (RP), and pain domains were substantially altered compared to the reference population. Age was negatively associated with PF, RP, role-emotional (RE), and social functioning (SF). Tumor size and lymph node metastases affected general health and PF, respectively. The cancer-free survival duration was positively correlated with mental health (MH). Poor neck scar healing and persistent post-operative hypoparathyroidism significantly deteriorate MH. Pain perception was positively correlated with the radioactive iodine cumulative dose. Subclinical hyperthyroidism significantly reduced PF and RP scores. TSH suppression was negatively and strongly correlated with MH and SF scores. Conclusion: HRQoL is substantially reduced in DTC survivors compared to the normative Tunisian population. These results could be extrapolated to similar individuals in other South Mediterranean and African countries. The development of coordinated multidisciplinary aftercare interventions in this region is warranted to preserve HRQoL in DTC survivors.


Asunto(s)
Adenocarcinoma , Supervivientes de Cáncer , Neoplasias de la Tiroides , Adulto , Estudios Transversales , Femenino , Humanos , Radioisótopos de Yodo , Masculino , Persona de Mediana Edad , Calidad de Vida , Sobrevivientes
2.
Acta Biol Hung ; 61(2): 145-57, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20519169

RESUMEN

The present study was undertaken to assess the effect of selenium (Se) on hypothyroidism induced by methimazole (MMI) in lactating rats and their pups. Rats were randomly divided into four groups of six each: group I served as a negative control which received standard diet; group II received orally MMI (250 mg L -1 ); group II received both MMI (250 mg L -1 , orally) and Se (0.5 mg/kg of diet); group IV served as a positive control and received Se (0.5 mg Na 2 SeO 3 /kg of diet). Treatments were started from the 14th day of pregnancy until postnatal day 14. In the MMI-exposed group, the body weight of 14-day-old pups diminished compared to controls; besides, a hypertrophy of the thyroid glands was observed. Co-administration of Se through the diet restored these parameters to near normal values. In the MMI-treated group, thyroid iodine contents and plasma thyroid hormone levels significantly decreased, while plasma TSH levels increased in pups and their mothers. These biochemical modifications corresponded histologically to closed follicles, increased vascularity and a reduction in colloid volume. Co-treatment with Se ameliorated these parameters. We concluded that the supplementation of Se in diet had beneficial effects on hypothyroidism during a critical period of life.


Asunto(s)
Antitiroideos/farmacología , Hipotiroidismo/tratamiento farmacológico , Lactancia/efectos de los fármacos , Metimazol/farmacología , Selenio/farmacología , Animales , Conducta Alimentaria/efectos de los fármacos , Femenino , Humanos , Hipertrofia/patología , Masculino , Exposición Materna , Embarazo , Ratas , Ratas Wistar , Selenio/química
3.
J Recept Signal Transduct Res ; 29(2): 113-8, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19519176

RESUMEN

The receptors for thyroid hormone (THR) and oestrogen (ESR) are prototypes of nuclear transcription factors that regulate the expression of target genes. Genetic alterations in the genes of these receptors were found to be involved in cancer development. In this study we investigated the association of one SNP (rs2228480, T594T) and one microsatellite marker (D6S440) within the ESR1 gene and a dinucleotide repeat (D17S2189) within the THRA gene, with thyroid cancer risk. A case-control association study was conducted with 299 healthy individuals and 106 patients with thyroid cancer. Genotypic and allelic frequencies for the dinucleotide repeat in the ESR1 gene were similar between thyroid cancer patients and controls. For the AC repeat in the THRA gene, a slightly significant difference was found for the genotype 18/20 between the two groups (P = 0.034), which suggests that alleles with less than 20 repeats might have a protective effect in thyroid cancer risk. For the SNP T594T, the A allele was much more prevalent in patients than in controls and was highly associated with the risk of thyroid cancer (OR: 4,56; IC: 3.23-6.44; P < 10(-18)) and seems to have an additive mode of action. In conclusion, our data suggest that the SNP T594T but not the D6S440 and D17S189 is associated with thyroid cancer risk.


Asunto(s)
Receptor alfa de Estrógeno/genética , Frecuencia de los Genes/genética , Receptores alfa de Hormona Tiroidea/genética , Neoplasias de la Tiroides/genética , Adulto , Anciano , Alelos , Estudios de Casos y Controles , Femenino , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Masculino , Repeticiones de Microsatélite/genética , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple/genética , Neoplasias de la Tiroides/epidemiología , Túnez/epidemiología
4.
Nucl Med Commun ; 40(9): 888-893, 2019 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-31343615

RESUMEN

OBJECTIVE: The aim of this study was to compare the clinicopathological features of Hürthle cell carcinomas (HCC) and oncocytic papillary thyroid carcinomas (OPTC) and to evaluate their response to radioactive iodine (RAI) treatment. METHODS: We retrospectively reviewed the charts of patients with histopathologically verified OPTC (group 1) and HCC (group 2), during a 17-year period. All patients underwent total thyroidectomy and received RAI adjuvant therapy. Clinicopathological characteristics of the two groups were compared. Response to initial therapy was assessed 6 to 24 months after RAI ablation according to the American Thyroid Association dynamic risk reclassification. Clinical outcomes were evaluated. RESULTS: A total of 28 patients (8 OPTC and 20 HCC) were included. There was no significant difference in clinicopathological features including sex, age, tumour size and vascular invasion. Distant metastases were absent in both groups. OPTC, however, presented more features of local invasion (50% vs. 10%, P = 0.03), extrathyroidal extension (25% vs. 0%, P = 0.07) and lymph node involvement (37.5% vs. 0%, P = 0.01). Median cumulative RAI activity administered to both groups was 200 mCi (range: 100-300 mCi). Response to RAI therapy was excellent in all HCC and 87.5% of OPTC (P = 0.28). One patient with OPTC (12.5%) presented an indeterminate response. Clinical outcomes were favourable after a median follow-up of 87.5 and 49 months, respectively. CONCLUSION: Although OPTC presented more locoregional invasion, clinicopathological characteristics of OPTC and HCC were comparable. Both OPTC and HCC were iodine responsive. We suggest that adjuvant RAI therapy after total thyroidectomy is beneficial for OPTC and HCC and may improve disease-free survival.


Asunto(s)
Adenoma Oxifílico/patología , Adenoma Oxifílico/radioterapia , Radioisótopos de Yodo/uso terapéutico , Células Oxífilas/patología , Neoplasias de la Tiroides/patología , Neoplasias de la Tiroides/radioterapia , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Periodo Posoperatorio , Estudios Retrospectivos , Resultado del Tratamiento
5.
C R Biol ; 331(4): 262-71, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18355748

RESUMEN

The aim of this study was to determine the effects of thiocyanate on thyroid function in weaned mice. At this developmental period, induction and reversibility of thiocyanate effects have not yet been studied. In the present work, adult female mice were given thiocyanate [SCN(-) (1 g L(-1))] in their drinking water from the 15(th) day of pregnancy until either the 25(th) (group B) or the 15(th) day (group C) after parturition. During five days after weaning, water and food consumptions of treated mice (group B) were 42.2+/-1.2% and 56.4+/-0.9%, respectively, less than those of the controls (group A). On the sacrifice day (the 25(th) day after birth), body weight, thyroid iodine content and thyroid hormone levels (FT(4) and FT(3)) decreased by 10.4+/-3.0%, 40.6+/-2.3%; 18.7+/-2.3% and 18.1+/-1.3%, respectively. Plasma TSH increased by 30.6+/-1.7% along with the hypertrophy of thyroid glands (52.6+/-3.1%). We have observed a hypertrophy of follicle cells and a decrease in colloid volume within histological slides. After SCN(-) withdrawal (group C), partial or total recovery were noted in all parameters studied. We concluded that hypothyroidism effects added to the weaning event affected greatly thyroid function and behaviour of mice; these would be largely reversed by withdrawing thiocyanate treatment for a period of ten days.


Asunto(s)
Tiocianatos/farmacología , Glándula Tiroides/fisiología , Animales , Tamaño Corporal/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Conducta de Ingestión de Líquido/efectos de los fármacos , Conducta Alimentaria/efectos de los fármacos , Masculino , Ratones , Tamaño de los Órganos/efectos de los fármacos , Pruebas de Función de la Tiroides , Glándula Tiroides/efectos de los fármacos , Tiroxina/sangre , Triyodotironina/sangre , Destete
7.
Biomed Pharmacother ; 103: 1115-1126, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29715755

RESUMEN

Bisphenol A (BPA) can disturb the endocrine system and the organs that respond to endocrine signals in organisms, indirectly exposed during prenatal and/or early postnatal life. The present study was designed to assess the protective effect of phenolic compounds from olive leaves against BPA induced thyroid dysfunction and growth perturbation in young rats during lactation. The BPA disrupting effect on thyroid function was investigated by measuring changes in plasma levels of thyroid hormones. Free triiodothyronine (FT3) and thyroxine (FT4) were decreased in young rats breast-fed from mothers treated with bisphenol A. This effect was associated with an increase in the plasma level of thyroid-stimulating hormone (TSH). The histological and immunohistochemical study of the thyroid gland revealed a disturbance in morphological structure and thyroid cells function. Thyroid dysfunction led to a disruption in the skeletal bone growth of young rats. In fact, the infrared microspectroscopic analysis and histological examination of femoral bone showed significant changes in their histoarchitecture associated with a perturbation in the mechanism of bone tissue mineralization. The administration of oleuropein or hydroxytyrosol in BPA treated lactating mothers improved the thyroid cells function by enhancing thyroid hormone levels. Moreover, these phenolics increased the body growth characterized by an amelioration in the structure and the microstructure of femoral bone tissue. HPLC analysis of rats-breast milk indicated the presence of oleuropein and hydroxytyrosol, which could contribute to the protective effect against bisphenol A induced hypothyroidism in pups rats.


Asunto(s)
Compuestos de Bencidrilo/toxicidad , Disruptores Endocrinos/toxicidad , Hipotiroidismo/prevención & control , Iridoides/uso terapéutico , Fenoles/toxicidad , Alcohol Feniletílico/análogos & derivados , Sustancias Protectoras/uso terapéutico , Animales , Animales Lactantes , Femenino , Hipotiroidismo/sangre , Hipotiroidismo/inducido químicamente , Glucósidos Iridoides , Iridoides/aislamiento & purificación , Lactancia , Olea/química , Alcohol Feniletílico/aislamiento & purificación , Alcohol Feniletílico/uso terapéutico , Hojas de la Planta/química , Ratas , Hormonas Tiroideas/sangre
8.
Bioresour Technol ; 97(16): 2136-40, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16290138

RESUMEN

The present research was undertaken to evaluate some biological parameters in rats fed with a supplemented diet with Opuntia ficus indica powder seeds. Feed intake and body weight of rats were measured every two days during nine weeks of treatment. Digestibility, feed conversion efficiency and protein efficiency ratio were determined. No difference in digestibility was noticed between the different diets. The results indicated a significant decrease in body weight of rats receiving a diet partially substituted with O. ficus indica powder seeds, probably due to a significant decrease in serum-free thyroxin (FT(4)) compared to the control group. In the treated group, a decrease of glucose concentration in blood and an increase of glycogen in liver and skeletal muscle were noticed. A significant increase in HDL-cholesterol was noted in the group receiving the supplemented diet with O. ficus indica powder seeds. These results suggest that O. ficus indica seeds can be used as a healthy food.


Asunto(s)
Fenómenos Fisiológicos Nutricionales de los Animales , Suplementos Dietéticos/análisis , Opuntia , Semillas/química , Animales , Glucemia , Peso Corporal/fisiología , Fenómenos Fisiológicos del Sistema Digestivo , Ingestión de Alimentos/fisiología , Heces/química , Glucógeno/metabolismo , Hígado/metabolismo , Masculino , Músculo Esquelético/metabolismo , Ratas , Ratas Wistar
9.
Exp Toxicol Pathol ; 57(5-6): 437-43, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16616466

RESUMEN

OBJECTIVE: to determine whether magnesium (Mg) supplementation could have a protective effect against the cadmium (Cd)-induced oxidative stress in liver, kidneys and testes of adult male rats. Stress was evaluated by measuring lipid peroxidation by thiobarbituric acid reactive substances (TBARS) and the heat shock protein (HSP) 72/73 expression. CdCl2 injections (2.5mg/day/kg body weight) for 10 days resulted in a time dependent increase of Cd accumulation in liver, kidney and testes, the highest levels being found in liver (400 microg/g dried tissue). At the same time, an increase of lipid peroxidation was observed. The effect was maximal at day 1 of Cd treatment in liver and testes, and later (day 5) in kidney. Then, Cd-induced lipid peroxidation decreased, suggesting the activation of antioxidant defense mechanisms. Injections of Mg SO4 (300-600 mg/day/kg body weight) reduced in a dose-dependent manner Cd-induced lipid peroxidation in liver and kidney as well as the accumulation of Cd in liver, kidney and testes. In testes, a protective effect of Mg was found only during the early phase of Cd-poisoning. On days 5 and 10, lipid peroxidation was even increased as compared to controls. In liver and testes only the constitutive HSP73 was detected whereas in kidney both HSP73 and the inducible HSP72 were expressed. HSP72/73 expression was not significantly increased by Cd and HSP73 was even lowered in kidney, probably due to the strong dose used. These results were not modified by Mg injections. CONCLUSION: Mg supplementation can reduce Cd accumulation in organs and lipid peroxidation related to Cd administration.


Asunto(s)
Cloruro de Cadmio/toxicidad , Carcinógenos Ambientales/toxicidad , Proteínas del Choque Térmico HSP72/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Magnesio/farmacología , Animales , Cloruro de Cadmio/farmacocinética , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Proteínas del Choque Térmico HSP72/metabolismo , Riñón/efectos de los fármacos , Riñón/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Magnesio/farmacocinética , Masculino , Ratas , Ratas Wistar , Testículo/efectos de los fármacos , Testículo/metabolismo , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
10.
C R Biol ; 328(10-11): 900-11, 2005.
Artículo en Francés | MEDLINE | ID: mdl-16286079

RESUMEN

The present study, carried out in rats, is a contribution to explore physiological mechanisms underlying lithium toxicity. Male and female mature rats were divided into three groups and fed on commercial pellets: group (C) was control, group (Li1) was given 2000 mg lithium carbonate/kg of food, and group (Li2) was given 4000 mg lithium carbonate/kg of food. If we take into account the BW of the rats and the quantity of food they eat every day, we can estimate that the quantities of lithium carbonate ingested per day and kilogram of BW are, respectively, for the groups Li1 and Li2, of 212 mg (5,738 mmol Li) and 323 mg (8,742 mmol Li) for the males, and about 190 mg (5,142 mmol Li) and 289 mg (7,822 mmol Li) for the females. After 7, 14, 21 and 28 days, serum concentrations of lithium, creatinine, free triiodothyronine (FT3) and thyroxine (FT4), testosterone and estradiol were measured. Attention was also paid to growth rate and a histological examination of testes or vaginal mucosa was carried out. In treated rats, a dose-dependent loss of appetite and a decrease in growth rate were observed together with polydipsia, polyuria, and diarrhoea. Lithium serum concentrations were found to increase from 0.44 mM (day 7) to 1.34 mM (day 28) in Li1 rats and from 0.66 to 1.45 mM (day 14) in Li2 rats. Treatment was stopped at day 14 in Li2 rats because of a high mortality. The significant increase of creatinine that appeared, respectively, at day 7 and 14 in Li2 and Li1 rats shows that serum lithium concentrations ranging from 0.62 to 0.75 mM were able to induce renal insufficiency, secondarily leading to a time-dependent rise in lithium serum concentrations. A significant decrease of serum thyroxine (FT4) and triiodothyronine (FT3) levels was observed for lithium concentrations ranging from: 0.66 to 0.75 mmol l(-1) (Li2 rats) to 1.27 mmol l(-1) (Li1 rats). This effect was more pronounced for FT3, suggesting a defect of FT4/FT3 conversion. Under lithium treatment, the testosterone level decreased and spermatogenesis was stopped. By contrast, in treated female rats, estradiol level was found to be increased in a dose-dependent manner and animals were blocked in the diestrus phase at day 28. These results show that lithium can rapidly induce toxic effects in the rat at concentrations used for the treatment of bipolar disorders in human.


Asunto(s)
Riñón/fisiología , Litio/sangre , Litio/deficiencia , Conducta Sexual Animal/fisiología , Glándula Tiroides/fisiología , Animales , Peso Corporal/fisiología , Creatinina/sangre , Ingestión de Alimentos/fisiología , Ciclo Estral/fisiología , Femenino , Hormonas Esteroides Gonadales/sangre , Masculino , Ratas , Ratas Wistar , Testículo/anatomía & histología , Hormonas Tiroideas/sangre
11.
Presse Med ; 44(3): e67-74, 2015 Mar.
Artículo en Francés | MEDLINE | ID: mdl-25595819

RESUMEN

OBJECTIVE: To study the characteristics of ocular metastases of thyroid carcinomas through three observations of patients. RESULTS: Three patients aged respectively 41, 55 and 66 years were followed for thyroid carcinoma. All patients were treated by surgery followed by IRA therapy. They developed ocular metastases after a mean period of 10 years after thyroidectomy. They presented in addition multiple secondary sites such as bone, lungs and cerebrum. The uveal lesion was unilateral and localized at the choroid or iris. The predominant symptomatology was decreased visual acuity. The diagnosis was based on ophthalmoscopic examination and post-IRA therapy scan and was confirmed by anatomopathological study. Treatment options were respectively IRA therapy, sectoral iridectomy and enucleation. Evolution was fatal in 2 cases and towards aggravation for one case. CONCLUSION: Uveal metastases of thyroid cancer are associated with a pejorative prognosis. Ophthalmologic follow-up is necessary when patient presents warning sign mainly with metastatic follicular carcinoma. Conversely, thyroid carcinoma should be considered in the differential diagnosis of a uveal mass of unknown origin.


Asunto(s)
Adenocarcinoma Folicular/patología , Neoplasias de la Tiroides/patología , Neoplasias de la Úvea/secundario , Adenocarcinoma Folicular/diagnóstico , Adulto , Anciano , Diagnóstico Diferencial , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias de la Tiroides/diagnóstico , Neoplasias de la Úvea/diagnóstico
12.
Ther Adv Endocrinol Metab ; 6(5): 181-8, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26445640

RESUMEN

OBJECTIVES: The aim of this study was to explore the oxidative stress profile in hashitoxicosis (HTX) and to compare it with that of healthy subjects. PATIENTS AND METHODS: Spectrophotometric methods were used to evaluate the oxidative stress markers. The selenium level was investigated by atomic absorption. RESULTS: High levels of thiobarbituric acid reactive species (TBARS) and conjugated dienes were found in HTX patients (p = 0.034 and p = 0.043, respectively) compared with healthy controls. For antioxidant enzymes, superoxide dismutase (SOD) and catalase activities increased, whereas that of glutathione peroxidase (GPx) decreased (p = 0.000, p = 0.014, p = 0.000, respectively) compared with controls. A reduction in the level of selenium (p = 0.029) and thiol groups (p = 0.008) were shown in patients; however, levels of carbonyl group and malondialdehyde (MDA) protein adducts decreased (p = 0.000) compared with controls. Positive correlation was shown between levels of free thyroxine (FT4) and TBARS (r = 0.711, p = 0.048) and between FT4 level and SOD activity (r = 0.713, p = 0.047). Conversely, GPx activity presented a negative correlation with FT4 and free triiodothyronine (FT3) levels (r = -0.934, p = 0.001; r = -0.993, p = 0.000, respectively). In addition, GPx activity showed positive correlation with selenium level (r = 0.981, p = 0.019) and the FT3 level correlated negatively with the level of thiol groups (r = -0.892, p = 0.017). CONCLUSIONS: This study shows the presence of an oxidative stress and selenium deficiency in HTX patients and suggests that the hyperthyroid state is strongly implicated in the establishment of this disturbed oxidative profile.

13.
Intensive Care Med ; 30(3): 461-7, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-14673518

RESUMEN

OBJECTIVE: To explore the myocardial perfusion by thallium-201 scintigraphy for patients with evidence of myocardial damage after scorpion envenomation. DESIGN: Prospective study over 1-year period. SETTING: Medical intensive care unit of a university hospital (Sfax, Tunisia). PATIENTS: We have prospectively included six patients admitted for scorpion envenomation over a period of 1 year in the 22-bed intensive care unit (ICU) of our university hospital. The evidence of myocardial damage was confirmed by electrocardiography and echocardiography in all patients. Myocardial perfusion scintigraphy ((201)Tl scintigraphy) coupled with radionuclide ventriculography ((99m)Tc) was performed for all patients, occurring 32 h on average (range 12-72 h) after the sting. RESULTS: Radionuclide ventriculography was abnormal in all cases; the abnormalities observed were similar to those observed by echocardiography. Moreover (201)Tl scintigraphy showed evidence of myocardial hypoperfusion in all cases. The myocardial hypoperfusion grade and localisation were more marked in the abnormal localisation shown by echocardiography and electrocardiography, compared to the normal wall. Repeated studies, obtained only in two patients within 6 and 15 days, respectively, showed considerable, but not complete, improvement of wall motion and myocardial perfusion. Segments with improved perfusion showed greatly improved regional wall motion. CONCLUSION: This study confirms the evidence of myocardial hypoperfusion after severe scorpion envenomation.


Asunto(s)
Isquemia Miocárdica/diagnóstico por imagen , Isquemia Miocárdica/etiología , Angiografía por Radionúclidos , Picaduras de Escorpión/complicaciones , Escorpiones , Adulto , Animales , Niño , Preescolar , Femenino , Humanos , Masculino , Estudios Prospectivos , Radioisótopos , Talio , Tomografía Computarizada de Emisión de Fotón Único
14.
C R Biol ; 325(9): 927-40, 2002 Sep.
Artículo en Francés | MEDLINE | ID: mdl-12481686

RESUMEN

This study deals with the impact of chronic exposure to lead on male and female fertility in rats. Male and female rats (3 months old) were fed on commercial tablets (SICO, Sfax). For drinking, some rats were given distilled water (T = controls), the other ones were given distilled water enriched with lead acetate, either 3 (P1 group) or 6 mg ml-1 (P2 group), for 15, 30, 45, 60 or 90 days. In male rats, absolute and relative weights of testis, epididymis, prostate and seminal vesicles were found to significantly decrease at day 15 in the P2 group and at day 45 in the P1 group. However, at day 60, these absolute and relative weights returned to control values. Lead-induced pathological changes in spermatogenesis were observed at day 15 by histological study: arrest of cell germ maturation, changes in the Sertoli cells, and presence of apoptotic cells revealed by borated toluidine blue in the testis. Presence of lead deposits was observed after histochemical staining using sodium rhodizonate. Serum testosterone level was found to be lowered at day 15 in both (P1) and (P2) groups, to display a peak at day 60, then to return to controls values, in spite of the continuation of the treatment. In female rats, absolute and relative weights of ovary and uterus were found unchanged. The vaginal smears practiced in females revealed the oestrus phase in all groups. Exposed females were mated with control males, and fecundity was assessed 15 days later by counting the number of pregnancies and the number of concepti per pregnancy. Fertility was found to be reduced in females of P1 and P2 groups as compared to control females (T group). Lead level in blood was found to be poorly correlated with the level of poisoning, whereas lead accumulation in tail was found to be dose-dependent. Therefore, lead accumulation in tail appears as a more reliable biomarker of exposure to lead. In summary, our study shows that chronic exposure to lead causes a double sexual disorder in rats: first, disorder deals with the hormonal function, which is affected at the early stages of poisoning, but is rapidly corrected; second, disorder deals with the genital tract, affecting the testis and the ovary, resulting in a reduced fertility in both P1 and P2 females, in spite of the presence of a normal oestrus. The cytotoxic effect of lead in males seems to be related to an apoptotic process.


Asunto(s)
Apoptosis/efectos de los fármacos , Infertilidad Femenina/inducido químicamente , Infertilidad Masculina/inducido químicamente , Intoxicación por Plomo/complicaciones , Reproducción/efectos de los fármacos , Maduración Sexual/efectos de los fármacos , Administración Oral , Animales , Quelantes/farmacología , Ciclohexanonas/farmacología , Ciclo Estral/efectos de los fármacos , Femenino , Genitales Femeninos/efectos de los fármacos , Genitales Femeninos/patología , Genitales Masculinos/efectos de los fármacos , Genitales Masculinos/patología , Infertilidad Femenina/fisiopatología , Infertilidad Masculina/fisiopatología , Plomo/sangre , Plomo/farmacocinética , Plomo/toxicidad , Intoxicación por Plomo/fisiopatología , Tamaño de la Camada/efectos de los fármacos , Masculino , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Wistar , Espermatogénesis/efectos de los fármacos , Cola (estructura animal)/química , Testosterona/sangre
15.
Indian J Endocrinol Metab ; 18(2): 185-90, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24741514

RESUMEN

INTRODUCTION: The differentiated thyroid cancers have a good prognosis unless the presence of metastasis. These distant metastases, especially in bone, are a major cause of impaired quality of life and death requiring intensive management. The aim of our work was to study the patients' data, the disease characteristics and to analyze the therapeutic management of these patients. RESULTS: This study concerned a cohort of 21 patients treated for differentiated thyroid cancer during the period from 1995 to 2011. Eighteen of our patients were aged over 45 years. A majority of them had follicular carcinoma. Bone metastases were often multiple and located at the axial skeleton. They were associated with other types of metastases, especially lung metastasis. A majority of patients received 131I treatment, following surgery or external beam radiotherapy for a palliative purpose. Overall survival was 65% at 5 years and 49% at 10 years. A long-term survival was achieved in 10% of the patients benefiting from a multidisciplinary care adapted to each case. CONCLUSION: Bone metastases often have a pejorative turning in the natural history of differentiated thyroid cancers. The right selection of individuals with better prognosis, for whom more aggressive curative treatment was indicated, requires a better understanding of the features of bone involvement.

17.
Exp Toxicol Pathol ; 64(3): 187-95, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20833006

RESUMEN

AIMS: Selenium has a pharmacological properties and it is well considered as an antioxidant. The present study investigated the potential ability of selenium, used as a nutritional supplement, to alleviate bone impairments in suckling rats whose mothers were treated with methimazole, an antithyroid drug. MAIN METHODS: Female Wistar rats were randomly divided into four groups of six each: group I served as control which received standard diet; group II were rendered hypothyroid by administration of methimazole (250 mg L(-1) in their drinking water); group III received both methimazole (250 mg L(-1) in their drinking water) and selenium (0.5 mg kg(-1) of diet); group IV received 0.5 Na(2)SeO(3) mg kg(-1) of diet. Treatments were started from the 14th day of pregnancy until day 14 after delivery. KEY FINDINGS: Methimazole treatment decreased femur length and weight in 14-day-old rats, when compared to controls. Femur antioxidant enzyme activities, superoxide dismutase, catalase and glutathione peroxidase decreased. Lipid peroxidation recorded an increase revealed by high femur malondialdehyde levels. Methimazole also caused a significant decrease in calcium and phosphorus levels in bone. Yet, in plasma and urine, they increased and decreased inversely. Besides, plasma total tartrate-resistant acid phosphatase was enhanced, while total alkaline phosphatase was reduced. Co-administration of selenium through diet improved the biochemical parameters cited above. Nevertheless, distorted histoarchitecture revealed in hypothyroid rat femur was alleviated by Se treatment. SIGNIFICANCE: The present study suggests that selenium is an important protective element that may be used as a dietary supplement protecting against bone impairments.


Asunto(s)
Antioxidantes/farmacología , Antitiroideos/toxicidad , Fémur/efectos de los fármacos , Metimazol/toxicidad , Efectos Tardíos de la Exposición Prenatal/prevención & control , Selenio/farmacología , Animales , Animales Recién Nacidos , Suplementos Dietéticos , Agua Potable , Femenino , Fémur/patología , Embarazo , Efectos Tardíos de la Exposición Prenatal/patología , Ratas , Ratas Wistar
18.
Biol Trace Elem Res ; 142(3): 598-610, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20820944

RESUMEN

Mercuric chloride (HgCl(2)) has been shown to affect the male reproductive organs, and oxidative stress has been linked with hypospermatogenesis and with male infertility. However, the specific mode of impairment of spermatogenesis during HgCl(2) exposure has not yet been clarified fully. Because of the involvement of 17ß-estradiol (E2) in the male reproductive tract and its putative role on spermatogenesis, the present study aimed to investigate the possibility that HgCl(2)-induced oxidative stress-mediated modulation of the E2 level exerts adverse effects on testicular steroidogenic and gametogenic activities. HgCl(2) treatment at 50 and 100 ppm for 90 days by continuous oral administration in the drink water resulted in significant dose-dependent fashion decrease in serum and testicular E(2) levels and an increase in testicular testosterone levels in dose-dependent manner, without statistical alteration in serum testosterone level among HgCl(2) exposed groups compared to the control. Cauda epididymal sperm count and motility were decreased significantly (p < 0.01), in a dose-dependent manner, in the HgCl(2)-treated groups, and qualitative examination revealed inhibition of spermatogenesis and the preferential loss of maturing and elongated spermatids. The seminiferous tubules were dilated in treated animals. When compared to the control, increase in lipid peroxidation due to toxic effects of HgCl2 was accompanied by significant reduction (p < 0.01) in antioxidant enzymes activities, superoxide dismutase, catalase, and glutathione peroxidase of testes, implicating the presence of oxidative tissue damage. Furthermore, these tissue injuries caused functional impairment as evidenced with testicular elevated activity of lactate dehydrogenase. Unless oxidative stress can lead to cancer development, testis' tumor markers as beta human chorionic gonadotropin and alpha-fetoprotein levels have shown no significant differences in the HgCl(2)-exposed group compared with respect to the control. Large quantities of metal accumulated in the testis tissue are in agreement with the testis-activity failure verified in this tissue. These findings suggest that a decrease in E2 level after mercury exposure may render testis more susceptible to oxidative damage leading to its functional inactivation, thus providing new dimension to mechanisms underlying heavy metal-induced male infertility.


Asunto(s)
Estradiol/metabolismo , Cloruro de Mercurio/toxicidad , Estrés Oxidativo/efectos de los fármacos , Espermatogénesis/efectos de los fármacos , Animales , Catalasa/metabolismo , Glutatión Peroxidasa/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Radioinmunoensayo , Ratas , Ratas Wistar , Recuento de Espermatozoides , Motilidad Espermática/efectos de los fármacos , Superóxido Dismutasa/metabolismo , Testículo/efectos de los fármacos , Testículo/metabolismo
19.
Biofactors ; 37(6): 429-38, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22009886

RESUMEN

Gibberellic acid (GA3) has been worldwide used in agriculture as a plant growth regulator. The purpose of this study is to assess the effects of GA3 on the morphology and the thyroid hormone levels in adult rats and their suckling pups. Animals were given daily 200 ppm GA3 in drinking water from the 14th day of pregnancy until day 14 after delivery. Compared with a control group, GA3-treated mothers and pups showed an increase in body and thyroid weights, a decrease in plasma FT4 and FT3 levels, which were more pronounced in pups than in their mothers. Thyroid iodine content was also decreased in pups. These biochemical modifications corresponded histologically; the majority of follicles had cubical epithelial cells, which surrounded empty vesicular cavities. Toxicity was objectified by a significant increase in plasma malondialdehyde, protein carbonyls, and advanced oxidation protein products levels in GA3-treated dams and their suckling pups; while, the activities of superoxide dismutase, catalase, and glutathione peroxidase were decreased in plasma of both dams and their pups. Moreover, a significant decline was observed in plasma glutathione, nonprotein thiols, and vitamin C levels. We conclude that GA3 treatment affects thyroid function and plasma antioxidant status in adult rats and their progeny.


Asunto(s)
Contaminantes Ambientales/toxicidad , Giberelinas/toxicidad , Lactancia , Estrés Oxidativo , Plaguicidas/toxicidad , Glándula Tiroides/efectos de los fármacos , Acetilcolinesterasa/sangre , Animales , Animales Lactantes , Antioxidantes/metabolismo , Peso Corporal/efectos de los fármacos , Butirilcolinesterasa/sangre , Femenino , Peroxidación de Lípido/efectos de los fármacos , Masculino , Intercambio Materno-Fetal , Tamaño de los Órganos , Embarazo , Carbonilación Proteica/efectos de los fármacos , Distribución Aleatoria , Ratas , Ratas Wistar , Glándula Tiroides/patología , Glándula Tiroides/fisiopatología , Tiroxina/sangre , Triyodotironina/sangre
20.
Biol Trace Elem Res ; 138(1-3): 107-15, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20204550

RESUMEN

The aim of this study was to evaluate and compare the oxidative profiles of three thyroid disorders: Graves' disease (GD), Hashimoto thyroiditis (HT), and papillary thyroid cancer (PTC). Malondialdehyde levels (MDA), glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT) activities were examined in the plasma of 52 patients (29 untreated HT, 16 untreated GD, and 7 PTC who underwent surgical therapy). Results were compared with those of 30 healthy controls and among the three groups of patients. The GD, HT, and PTC patients exhibited increased plasma MDA levels and SOD activities compared with the controls (p < 0.05, p < 0.05, and p < 0.001, respectively). CAT activities significantly increased only for the PTC and HT patients (p < 0.001 and p < 0.05, respectively), whereas GPx activities significantly decreased only in the GD and PTC (p < 0.05 and p < 0.01, respectively). The comparison among the three groups of patients has shown increased MDA level and SOD activity for the PTC patients as compared to the GD patients (p < 0.01 and p < 0.001, respectively). Compared with HT, PTC patients exhibited significant higher MDA level, SOD, and CAT activities and a significant lower GPx activity (p < 0.01, p < 0.001, p < 0.05, and p < 0.05, respectively). No significant discrepancies were noted between the GD and HT patients. Our results have clearly shown an oxidative profile that is highly disturbed for the PTC patients as compared to those of autoimmune disorders. Future studies are needed to determine whether or not the oxidative stress has a prognostic value in this pathology.


Asunto(s)
Enfermedad de Graves/metabolismo , Enfermedad de Hashimoto/metabolismo , Adulto , Carcinoma , Carcinoma Papilar , Catalasa/metabolismo , Femenino , Glutatión Peroxidasa/metabolismo , Humanos , Peroxidación de Lípido/fisiología , Masculino , Malondialdehído/metabolismo , Persona de Mediana Edad , Estrés Oxidativo/fisiología , Superóxido Dismutasa/metabolismo , Cáncer Papilar Tiroideo , Neoplasias de la Tiroides/metabolismo , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA